Valuation : Photocure ASA

Market Cap 1.4B 150M 130M 123M 111M 209M 14.37B 210M 1.46B 560M 7.31B 565M 553M 23.1B P/E 2026 *
18.3x
P/E 2027 * 66.5x
Enterprise Value 1.23B 132M 114M 108M 97.78M 183M 12.63B 184M 1.28B 493M 6.43B 497M 486M 20.31B EV / Sales 2026 *
1.87x
EV / Sales 2027 * 1.86x
Free-Float
94.52%
Yield 2026 *
-
Yield 2027 * -
1 day-2.44%
1 week-2.99%
Current month-4.77%
1 month-0.38%
3 months-10.36%
6 months-25.22%
Current year-27.31%
1 week 51.9
Extreme 51.9
54.2
1 month 51.9
Extreme 51.9
60.5
Current year 46.25
Extreme 46.25
79.8
1 year 46.25
Extreme 46.25
79.8
3 years 41.7
Extreme 41.7
79.8
5 years 40.7
Extreme 40.7
127.3
10 years 21.5
Extreme 21.5
154.5
Manager TitleAgeSince
Chief Executive Officer - 2018-10-31
Chief Tech/Sci/R&D Officer - 2021-07-31
Human Resources Officer - 2021-01-31
Director TitleAgeSince
Director/Board Member - 2021-12-31
Chairman - 2023-09-26
Director/Board Member - 2024-05-22
Date Insider Type Main position Quantity % Market Cap. Importance
4/2/25 BuyCompany 11,355 0.0419%
4/2/25 BuyCompany 8,997 0.0332%
3/31/25 BuyCompany 27,113 0.1000%
Change 5-day change 1-year change 3-year change Capi.($)
-2.44%-2.99%-14.64%+17.02% 150M
-0.65%-2.93%+47.52%+87.34% 994B
-0.29%-3.51%+48.78%+63.27% 640B
+0.83%+0.26%+16.76%+72.52% 454B
-0.38%-3.59%+28.24%+35.57% 337B
-0.09%-13.54%+10.08%+26.87% 261B
-0.43%-2.48%-2.07%+11.48% 246B
-1.34%-13.70%+33.47%+44.18% 204B
-3.44%-7.51%-20.08%-59.58% 190B
-0.75%-4.82%+21.94%+86.55% 178B
Average -0.90%-5.48%+17.00%+38.52% 350.49B
Weighted average by Cap. -0.51%-4.42%+29.86%+55.71%

Financials

2026 *2027 *
Net sales 658M 70.89M 61.08M 57.83M 52.42M 98.34M 6.77B 98.84M 687M 264M 3.45B 266M 260M 10.89B 666M 71.75M 61.82M 58.54M 53.06M 99.54M 6.85B 100M 695M 267M 3.49B 269M 264M 11.02B
Net income 76.33M 8.22M 7.08M 6.71M 6.08M 11.4M 785M 11.46M 79.64M 30.63M 400M 30.87M 30.19M 1.26B 21M 2.26M 1.95M 1.84M 1.67M 3.14M 216M 3.15M 21.91M 8.43M 110M 8.49M 8.31M 347M
Net Debt -169M -18.2M -15.68M -14.85M -13.46M -25.25M -1.74B -25.37M -176M -67.81M -884M -68.34M -66.84M -2.79B -157M -16.91M -14.57M -13.79M -12.5M -23.45M -1.62B -23.57M -164M -62.99M -822M -63.49M -62.1M -2.6B
Logo Photocure ASA
Photocure ASA is a Norway-based company active in the pharmaceutical industry. The Company is focused on developing and improving photodynamic technology and owns a Photocure Technology platform, which develops photodynamic technology for diagnosis and therapy. Based on the Photocure Technology platform, Photocure has developed and commercialized Hexvix (Hyperthermic IntraVEsical Chemotherapy) and Cysview (hexaminolevulinate HCL) for use in bladder cancer. The Company’s activities are divided into two business segments: The Commercial Franchise and The Development Portfolio. The Commercial Franchise segment includes Hexvix/Cysview by geography (U.S. and Europe) and other sales (partners and other products including sales revenues for Hivec). The Development Portfolio segment includes development of pipeline products.
Employees
100
Date Price Change Volume
26-09-11 NOK 51.90 -2.44% 44,099
26-09-10 NOK 53.20 -0.19% 32,881
26-09-09 NOK 53.30 -0.37% 45,781
26-09-08 NOK 53.50 0.00% 62,593
26-09-07 NOK 53.50 0.00% 40,996
Trader
Investor
Global
Quality
ESG MSCI
-
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
3
Last Close Price
51.90NOK
Average target price
79.67NOK
Spread / Average Target
+53.50%

Quarterly revenue - Rate of surprise

40% Discount: Identify Tomorrow's Best Investments With The Best Subscriber-Only Tools!
d
:
:
SEIZE THE OFFER!